{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-138911","form_type":"8-K","ticker":"XOMA","cik":"0000791908","company_name":"XOMA Royalty Corp","filed_at":"2023-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.237690+00:00","generated_at":"2026-06-15T10:57:30.429733+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"XOMA Q1 2023 revenue drops to $0.4M; net loss widens to $9.8M; acquires IXINITY stream","bullets":["Total revenue of $0.4M in Q1 2023 vs $3.1M in Q1 2022; no milestone revenue recognized.","Net loss of $9.8M ($2.3M loss in Q1 2022) including $4.1M arbitration settlement costs.","Cash and equivalents $44.3M at March 31, 2023; no debt; operating cash burn $4.9M.","Acquired IXINITY commercial payment stream from Aptevo in March 2023; payments to begin Q2 2023.","Received second commercial payment from Roche for Vabysmo (faricimab) in February 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-138911","json":"https://secwatch.observer/filing/0001193125-23-138911.json","markdown":"https://secwatch.observer/filing/0001193125-23-138911.md","text":"https://secwatch.observer/filing/0001193125-23-138911.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/791908/000119312523138911/0001193125-23-138911-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/791908/000119312523138911/d450885d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T10:57:30.429733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"74c636ad6d3f5c1ebbd7e3a12d0b50051ae483c7","claim":"XOMA Royalty Corp reported first quarter of 2023 results: revenue $0.4 million, net income $9.8 million.","evidence_excerpt":"XOMA recorded total revenues of $0.4 million for the first quarter of 2023, compared with $3.1 million in the first quarter of 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/791908/000119312523138911/0001193125-23-138911-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter of 2023"},{"label":"Revenue","value":"$0.4 million"},{"label":"Net income","value":"$9.8 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}